SGHT
Sight Sciences IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$273.68M
P/E Ratio
—
EPS
$-0.70
Beta
2.38
52W High
$9.24
52W Low
$3.11
50-Day MA
$4.18
200-Day MA
$5.22
Dividend Yield
—
Profit Margin
-46.80%
Forward P/E
—
PEG Ratio
—
About Sight Sciences Inc
Sight Sciences Inc. (SGHT) is a pioneering medical technology firm focused on transforming the treatment of ocular diseases, with a primary emphasis on glaucoma management through innovative surgical and non-surgical approaches. The company is well-equipped with a robust product lineup and a comprehensive intellectual property portfolio, allowing it to capitalize on the escalating demand for minimally invasive ophthalmic therapies. With ongoing advancements in its distribution network and a commitment to advancing eye care technology, Sight Sciences offers a compelling opportunity for institutional investors aiming to participate in the dynamic healthcare sector.
Fundamentals
| Revenue (TTM) | $79.55M |
| Gross Profit (TTM) | $68.55M |
| EBITDA | $-27.01M |
| Operating Margin | -35.60% |
| Return on Equity | -56.60% |
| Return on Assets | -14.30% |
| Revenue/Share (TTM) | $1.51 |
| Book Value | $1.20 |
| Price-to-Book | 5.09 |
| Price-to-Sales (TTM) | 3.44 |
| EV/Revenue | 2.904 |
| EV/EBITDA | -4.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12.50% |
| Shares Outstanding | $54.41M |
| Float | $35.39M |
| % Insiders | 20.01% |
| % Institutions | 53.95% |
Historical Volatility
HV 10-Day
68.13%
HV 20-Day
102.82%
HV 30-Day
89.40%
HV 60-Day
103.43%
HV Rank
73.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.34 target)
1
Strong Buy3
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026